Inventor · disambiguated record
Richard Pfeifer
Also filed as: PFEIFER RICHARD
9 granted patents·7 pending applications·80 citations·filing 2011–2025
89Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES10TAKEDA PHARMACEUTICALS CO3CALIAS PERICLES1CONCINO MICHAEL F1NATOLI FARAH1
Top patents by PatentIndex Score
16 records- 0192US2025375506A1Cns delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 0291US11065308B2Methods and compositions for CNS delivery of heparan n-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted Jul 20, 2021·6 cites·5 claims
- 0391US10456454B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Oct 29, 2019·6 cites·27 claims
- 0491US9283181B2CNS delivery of therapeutic agentsCALIAS PERICLES·Filed 2011·Granted Mar 15, 2016·34 cites·6 claims
- 0589US11471516B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Oct 18, 2022·1 cites·17 claims
- 0689US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 0786US9320711B2Methods and compositions for CNS delivery of heparan N-sulfataseNATOLI FARAH·Filed 2011·Granted Apr 26, 2016·22 cites·43 claims
- 0885US12409210B2CNS delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 9, 2025·0 cites·5 claims
- 0983US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 1079US12161702B2Methods and compositions for CNS delivery of heparan N-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Dec 10, 2024·0 cites·19 claims
- 1163US2017042977A1Methods and compositions for cns delivery of heparan n-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Application pending·0 cites
- 1252US2022133863A1Treatment of sanfilippo syndrome type bSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Application pending·0 cites
- 1350US2018036386A1Methods and compositions for intrathecally administered treatment of mucupolysaccharidosis type iiiaSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 1448US2015313971A1Methods and compositions for intrathecally administered treatment of mucupolysaccharidosis type iiiaSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Application pending·0 cites
- 1542US2016030416A1Methods of treating b2-bradykinin receptor mediated angioedemaSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Application pending·0 cites
- 1635US2011318327A1Treatment of sanfilippo syndrome type bCONCINO MICHAEL F·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Pfeifer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →